Clinical Trials Browser

Phase 3 × Lung Neoplasms × adagrasib × Clear all

NCT06497556 2026-01-20

Krascendo 1

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms